Showing results (61-70 of 87) with videos related to
Sort By:
Pageof 9
Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies|December 25, 2013
Outcome of pediatric acute myeloid leukemia patients receiving intensive care in the United StatesShannon L Maude, Julie C Fitzgerald, Brian T Fisher, et al.Pediatric Blood & Cancer|September 9, 2022
Improving infectious adverse event reporting for children and adolescents enrolled in clinical trials for acute lymphoblastic leukemia: A report from the Children's Oncology GroupCaitlin W Elgarten, Joel C Thompson, Anne Angiolillo, et al.Haematologica|February 3, 2022
Temsirolimus combined with cyclophosphamide and etoposide for pediatric patients with relapsed/refractory acute lymphoblastic leukemia: a Therapeutic Advances in Childhood Leukemia Consortium trial (TACL 2014-001)Sarah K Tasian, Lewis B Silverman, James A Whitlock, et al.Journal of the National Cancer Institute|July 4, 2024
Optimizing early phase clinical trial washout periods: a report from the Therapeutic Advances in Childhood Leukemia and Lymphoma consortiumEric S Schafer, Teresa Rushing, Kristine R Crews, et al.The New England Journal of Medicine|October 16, 2014
Chimeric antigen receptor T cells for sustained remissions in leukemiaShannon L Maude, Noelle Frey, Pamela A Shaw, et al.Blood|November 9, 2022
Impact of poverty and neighborhood opportunity on outcomes for children treated with CD19-directed CAR T-cell therapyHaley Newman, Yimei Li, Hongyan Liu, et al.Blood Advances|August 15, 2025
Role of race and ethnicity in survival among children/young adults with relapsed ALL: a Children's Oncology Group reportJohn A Ligon, Lingyun Ji, Alice Dang, et al.Pediatric Blood & Cancer|January 17, 2020
Results from an international phase 2 study of the anti-CD22 immunotoxin moxetumomab pasudotox in relapsed or refractory childhood B-lineage acute lymphoblastic leukemiaNirali N Shah, Deepa Bhojwani, Keith August, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 22, 2016
Phase I/Phase II Study of Blinatumomab in Pediatric Patients With Relapsed/Refractory Acute Lymphoblastic LeukemiaArend von Stackelberg, Franco Locatelli, Gerhard Zugmaier, et al.Blood Neoplasia|June 30, 2026
Ixazomib with chemotherapy for childhood relapsed acute lymphoblastic leukemia: a TACL consortium reportEric S Schafer, Holly L Pacenta, Yueh-Yun Chi, et al.Pageof 9